WASHINGTON (Reuters) - U.S. regulators have started the process of revoking the approval of Roche Holding drug Avastin for treating breast cancer. European officials also have recommended restrictions ...
Here we go again. The U.S. Food and Drug Administration’s decision earlier this month to withdraw approval for the cancer drug Avastin for treating women with advanced breast cancer was met with ...
LONDON (Reuters) - AstraZeneca is dipping its toe in the biosimilars market, as a way to make future cancer drug cocktails more affordable, by linking with a Japanese group to develop a copy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback